CCO:TSXCameco Corporation Analysis
Data as of 2026-09-04 - not real-time
CA$139.44
Latest Price
9/10Risk
Risk Level: High
Executive Summary
Cameco Corporation trades at CAD 139.44, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 10.8%. With RSI at 53.2 the momentum picture is neutral, alongside a bearish MACD signal. Watch CAD 129.75 as support and CAD 154.65 as the nearer resistance level.
Multiples put this in overvalued territory: 174.3 times earnings against the sector's 17.8. Consensus targets land 28.9% above where the shares trade now. Revenue is contracting at 7.2% on a 10.2% profit margin. The 0.17% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 47.4%, a beta of 2.12 and a maximum drawdown of 34.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
Multiples put this in overvalued territory: 174.3 times earnings against the sector's 17.8. Consensus targets land 28.9% above where the shares trade now. Revenue is contracting at 7.2% on a 10.2% profit margin. The 0.17% dividend yield looks covered by current payout levels.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 47.4%, a beta of 2.12 and a maximum drawdown of 34.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Timeframes disagree: the short-term read is sell while the long-term read is hold, conviction 3 out of 10.
Top Market Events
Dominique Minière has resigned from Cameco’s Board of Directors after roughly three years of service.Cameco’s exposure to U.S. Saudi nuclear deal through Westinghouse Cameco TSX:CCO is in focus after attention turned...ECB and Eurozone inflation pressures are back in focus, with a potential September rate hike on the table.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 4/10
Key Factors
- Trading below the 200-day average of 146.09
- MACD momentum is negative
- 30-day price change of +10.8%
Medium Term
1–3 yearsCautious
Model confidence: 4/10
Key Factors
- P/E of 174.3 versus sector average of 17.8
- Trading below the 200-day average of 146.09
- Analyst targets imply +28.9% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 3/10
Key Factors
- P/E of 174.3 versus sector average of 17.8
- Analyst targets imply +28.9% versus the current price
- Revenue contracting at -7.2%
Key Metrics & Analysis
Financial Health
Revenue Growth-7.20%
Profit Margin10.21%
P/E Ratio174.3
ROE5.11%
ROA2.98%
Debt/Equity17.13
P/B Ratio8.5
Op. Cash FlowCA$941.8M
Free Cash FlowCA$50.0M
Industry P/E17.8
Technical Analysis
TrendNeutral
RSI53.2
SupportCA$129.75
ResistanceCA$154.65
MA 20CA$138.42
MA 50CA$134.02
MA 200CA$146.09
MACDBearish
VolumeStable
Fear & Greed Index95.48
Valuation
Fair ValueCA$1.20
Target PriceCA$179.73
Upside/Downside28.90%
GradeOvervalued
TypeGrowth
Dividend Yield0.17%
Risk Assessment
Beta2.12
Volatility47.38%
Sector RiskHigh
Reg. RiskHigh
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.